The forecast for hospital discharges related to hyperplasia of prostate in Canada shows a gradual decline from 2024 to 2028, decreasing from 13.24 thousand to 12.94 thousand. In 2023, the recorded discharges stood at a value slightly above these figures, indicating a consistent downward trend. Year-on-year analysis reveals a minor percentage decline, highlighting stability with a slight decrease each year. The compound annual growth rate (CAGR) over the five-year period also reflects this subtle decrease.
Future trends to watch for include advancements in medical treatments that could further reduce hospitalizations, as well as demographic changes that might influence the prevalence of prostate hyperplasia.
